KR101435163B1 - 항말라세지아제 - Google Patents

항말라세지아제 Download PDF

Info

Publication number
KR101435163B1
KR101435163B1 KR1020127020169A KR20127020169A KR101435163B1 KR 101435163 B1 KR101435163 B1 KR 101435163B1 KR 1020127020169 A KR1020127020169 A KR 1020127020169A KR 20127020169 A KR20127020169 A KR 20127020169A KR 101435163 B1 KR101435163 B1 KR 101435163B1
Authority
KR
South Korea
Prior art keywords
mastic
disk
malassezia
normal hexane
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020127020169A
Other languages
English (en)
Korean (ko)
Other versions
KR20120102801A (ko
Inventor
히데오 미노베
Original Assignee
가부시키가이샤 알라이안스
주식회사 메레데코리아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 가부시키가이샤 알라이안스, 주식회사 메레데코리아 filed Critical 가부시키가이샤 알라이안스
Publication of KR20120102801A publication Critical patent/KR20120102801A/ko
Application granted granted Critical
Publication of KR101435163B1 publication Critical patent/KR101435163B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
KR1020127020169A 2010-02-25 2010-04-30 항말라세지아제 Active KR101435163B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2010-039855 2010-02-25
JP2010039855A JP5578880B2 (ja) 2010-02-25 2010-02-25 抗マラセチア菌剤
PCT/JP2010/057658 WO2011104900A1 (ja) 2010-02-25 2010-04-30 抗真菌剤

Publications (2)

Publication Number Publication Date
KR20120102801A KR20120102801A (ko) 2012-09-18
KR101435163B1 true KR101435163B1 (ko) 2014-09-01

Family

ID=44506340

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127020169A Active KR101435163B1 (ko) 2010-02-25 2010-04-30 항말라세지아제

Country Status (5)

Country Link
US (1) US20120316144A1 (enExample)
JP (1) JP5578880B2 (enExample)
KR (1) KR101435163B1 (enExample)
CN (1) CN102905699A (enExample)
WO (1) WO2011104900A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5578880B2 (ja) * 2010-02-25 2014-08-27 株式会社アライアンス 抗マラセチア菌剤
CN103462993B (zh) * 2013-09-06 2015-07-22 嵊州市林美生物科技有限公司 Aphanamgrandiol A在制备抗人体真菌药物中的应用
DE112015004182T5 (de) * 2014-09-12 2018-01-11 Maruha Nichiro Corporation Antimykotische Zusammensetzung umfassend antimykotisches Peptid und Terpenalkohol
EP3468530A4 (en) 2016-06-10 2020-03-11 Clarity Cosmetics Inc. NON-COMEDOGEN FORMULA FOR HAIR AND SCALP CARE AND METHOD FOR USE
CN110269824A (zh) * 2019-07-19 2019-09-24 安徽宝利行香料有限公司 乳香提取物在日用品及洗涤用品中的应用
CN110754362B (zh) * 2019-11-28 2021-06-25 杭州创美生物科技有限公司 一种富硒金线莲的培养基及其培育方法
CN111000744B (zh) * 2020-01-07 2021-10-15 拉芳家化股份有限公司 一种含协同增效去屑组合的洗发香波

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002238496A (ja) 2001-02-19 2002-08-27 Araiansu:Kk 医療保健食品
WO2003092712A1 (en) 2002-05-01 2003-11-13 Lavipharm S.A. Use of mastic and its components for the control of microbial infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008292773A (ja) * 2007-05-24 2008-12-04 Casio Electronics Co Ltd 帯電ローラ
JP2010100596A (ja) * 2008-10-21 2010-05-06 Araiansu:Kk マスティックとスクワランを配合した薬剤耐性菌感染予防の組成物
JP5578880B2 (ja) * 2010-02-25 2014-08-27 株式会社アライアンス 抗マラセチア菌剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002238496A (ja) 2001-02-19 2002-08-27 Araiansu:Kk 医療保健食品
WO2003092712A1 (en) 2002-05-01 2003-11-13 Lavipharm S.A. Use of mastic and its components for the control of microbial infections

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Planta Medica. Vol. 65, No. 8, pp.749-752(1999.12.) *
Planta Medica. Vol. 65, No. 8, pp.749-752(1999.12.)*

Also Published As

Publication number Publication date
JP5578880B2 (ja) 2014-08-27
KR20120102801A (ko) 2012-09-18
JP2011173837A (ja) 2011-09-08
WO2011104900A1 (ja) 2011-09-01
CN102905699A (zh) 2013-01-30
US20120316144A1 (en) 2012-12-13

Similar Documents

Publication Publication Date Title
Silva et al. Anti-inflammatory, antioxidant, and antimicrobial activities of Cocos nucifera var. typica
Baqer et al. Quercetin, the potential powerful flavonoid for human and food: a review
Anand et al. An updated review of Terminalia catappa
Sun et al. Synergism of sophoraflavanone G with norfloxacin against effluxing antibiotic-resistant Staphylococcus aureus
US20200179473A1 (en) Anti-pathogenic compositions
TW200800140A (en) Antimicrobial agent and antimicrobial composition
Melguizo-Rodríguez et al. Biological effects of the olive tree and its derivatives on the skin
KR20120102801A (ko) 항진균제
Zheng et al. A review of the phytochemical and pharmacological properties of Amauroderma rugosum
Khalili et al. In vivo iron-chelating activity and phenolic profiles of the angel's wings mushroom, pleurotus porrigens (Higher Basidiomycetes)
JP2011173837A5 (enExample)
Bao et al. The effect of herbal medicine in innate immunity to Candida albicans
Aljassim et al. Evaluation of antimicrobial activity of ellagic acid on Methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, and Escherichia coli
Merino et al. Biological activities of hydroxyanthracene derivatives (HADs) from Aloe species and their potential uses
US20130337095A1 (en) Antimicrobial composition and its method of use
Vishala et al. A review on therapeutic benefits of active chemical moieties present in polyalthia longifolia
US11318182B1 (en) Plant extract for skin infections
EP3189837B1 (en) Use of flavonoid compound in preparation of composition for healing wound
CA3150752A1 (en) Croton lechleri compositions for use in treating bleeding, wounds and infections
KR100682979B1 (ko) 항균 감염증 및 항염증 작용에 대한 예방 치료용 조성물 및이를 이용하여 얻어진 무좀치료제
US6660761B2 (en) Method of treatment for fungal infections with a synergistic formulation of antifungal agents
Kumar et al. Anti-cancer efficacy and mechanisms of usnic acid
JP5925606B2 (ja) 抗真菌剤及びフケ抑制剤
KR20170065187A (ko) 티트리 잎 복합 추출물을 함유하는 여드름 개선용 화장료 조성물
KR20220014613A (ko) 균총 조절용 조성물

Legal Events

Date Code Title Description
A201 Request for examination
PA0105 International application

Patent event date: 20120731

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20120731

Comment text: Request for Examination of Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20130819

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20131227

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20140818

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20140821

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20140822

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20170711

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20170711

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20180816

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20180816

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20190626

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20190626

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20200624

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20220613

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20230612

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20240612

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20250625

Start annual number: 12

End annual number: 12